Please login to the form below

Not currently logged in
Email:
Password:

women's health

This page shows the latest women's health news and features for those working in and with pharma, biotech and healthcare.

Big Pharma, Little Pharma

Big Pharma, Little Pharma

The company took a big risk when it bought Allergan’s dermatology portfolio. ... to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and

Latest news

  • Teva wins FDA OK for crucial migraine drug Teva wins FDA OK for crucial migraine drug

    Teva wins FDA OK for crucial migraine drug. Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig. ... Since Schultz took the helm last year, Teva has been shedding staff and restructuring the business to cut costs, selling off its

  • FDA rejects Allergan’s uterine fibroid drug over safety concerns FDA rejects Allergan’s uterine fibroid drug over safety concerns

    The new measurements include contraindication in women with known liver problems, liver tests before, during and after treatment and liver monitoring literature. ... The news isn’t great for Allergan, which has said it sees Esmya as a flagship brand

  • VC raises new €270m fund for European biotechs VC raises new €270m fund for European biotechs

    It currently has around 25 companies in its portfolio, including Dutch gene therapy specialist UniQure, UK women’s health start-up KaNDy Therapeutics and US biotech Argos Therapeutics which as an ... Ernst &Young predicted earlier this year that

  • 'Femtech' poised to explode, with applications set to trigger healthcare disruption 'Femtech' poised to explode, with applications set to trigger healthcare disruption

    Will be driven by strong funding and positive regulatory environment. The market for digital applications for women’s health and wellbeing is set for ‘explosive growth’, driven by almost $1 billion ... Such femtech applications target reproductive,

  • MHRA suspends new prescriptions of fibroid drug Esmya MHRA suspends new prescriptions of fibroid drug Esmya

    In December, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the treatment for abnormal bleeding in women with uterine fibroids after four cases of serious liver injury - ... Allergan has said that it sees Esmya as a

More from news
Approximately 5 fully matching, plus 84 partially matching documents found.

Latest Intelligence

  • Advancing women in healthcare Advancing women in healthcare

    This theme was picked up in the HBA’s meeting in London, with a roundtable of women healthcare leaders hosted at Syneos Health by the President of Syneos Health Communications Europe, ... Dr Priya Agrawal is Business Unit Director, Vaccines &Women’s

  • If you’re going global, go local and go early If you’re going global, go local and go early

    Similarly, the inspiration for a recent global women’s cancer campaign originated from work with colleagues based in the Middle East - an area that might be considered an unconventional source for ... strategic and creative insights on women’s health

  • Pharma deals continue to slide Pharma deals continue to slide

    Novartis has announced a price of $475, 000 per treatment following discussion with health assessment authorities. ... The business has not performed because of generic price pressures so Teva has reduced its dividend, is laying off 7, 000 staff and is

  • Deal Watch March 2017 Deal Watch March 2017

    Duchesnay, the Canadian women’s health company, has acquired from Shionogi the rights to market Osphena, another oral treatment for dyspareunia, in North America. ... And that’s the news from the Deal Watch team, where the women are strong, the men

  • Deal Watch February 2017 Deal Watch February 2017

    women's health. ... Licence with co-promotion option. 2, 057. Cynosure/ Hologic. Medical aesthetics portfolio inc non-invasive body contouring, hair removal, skin revitalisation and women's health.

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

  • Topas Therapeutics appoints chief development officer and chief medical officer Topas Therapeutics appoints chief development officer and chief medical officer

    Topas Therapeutics has appointed Rupert Sandbrink as its new chief development officer and chief medical officer, a role that will see him lead the German group’s development and regulatory affairs. ... Prior to that, he held several roles at Bayer,

  • Anish Mehta appointed CEO of new women's health business Anish Mehta appointed CEO of new women's health business

    Anish Mehta appointed CEO of new women's health business. Will head up the former Teva portoflio CVC Capital Partners recently acquired. ... The combination of high quality products and a talented team creates a unique opportunity for us to build a

  • Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

    He was also chairman of GSK’s global R&D organisation for eight years and led the global integration of Novartis’vaccine unit into GSK. ... Additionally, Dr Frank Verwiel (pictured left). joins the group’s board of directors after serving ObsEva SA,

  • Clark Health Communications expands team Clark Health Communications expands team

    responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business. ... Campbell will support and assist the team across its women’s health, gastroenterology and haemophilia accounts.

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    Sam Agus takes up new role at Hansa Medical. Will focus on the firm’s lead kidney transplantation project IdeS. ... With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

  • Star announce PharmaDoctor partnership

    Already the UK’ s leading provider of pharmacy-based clinical service support packages, PharmaDoctor has recently broadened and strengthened their Medical, Commercial and Digital team capability to accelerate the expansion of ... in-pharmacy Clinics,

  • Star announce PharmaDoctor partnership

    Already the UK’ s leading provider of pharmacy-based clinical service support packages, PharmaDoctor has recently broadened and strengthened their Medical, Commercial and Digital team capability to accelerate the expansion of ... in-pharmacy Clinics,

  • Hanson Zandi

    BPH. Cardiovascular. Consumer health and nutrition. Contraception. Dermatology. Diabetes. GORD. Hepatitis C. ... Migraine. Monoclonal antibodies. Respiratory. Women’s Health.

  • Women's health in emerging markets

    Women's health in emerging markets. Why can understanding and improving women’ s health in emerging markets be challenging? ... Associate Director Rachel Howard and Research Manager Helen Mace discuss why market research is useful for understanding

  • Beyond Andrology: Trends in Men’s Health in Emerging Markets

    Beyond Andrology: Trends in Men’ s Health in Emerging Markets. Published in eyeforpharma July 2016 by Rachel Howard. ... Men’ s health in emerging markets is more likely to be brought about by tackling attitudes than by improving access.In my last

More from PMHub
Approximately 4 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics